🔎 Trials Near Me

Hjem › Prostatakreft › Michigan › Ann Arbor

Kliniske studier for Prostatakreft i Ann Arbor, MI

27 studier for Prostatakreft søker deltakere på steder i og rundt Ann Arbor (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

RekruttererFase 3
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi unna
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi unna
Alder 18 og eldre · Menn · Oppdatert 2. okt. 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

RekruttererFase 3
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Alder 18 og eldre · Menn · Oppdatert 2. okt. 2026 · NCT07200830

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 mi unna
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
  • og 4 flere
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

RekruttererFase 2
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi unna
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06632977

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

RekruttererFase 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 mi unna
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
  • og 4 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382

Precision-Based Genomics in Prostate Cancer

RekruttererObservasjonsstudie
  • University of Michigan, Ann Arbor
Alder 18 til 120 · Menn · Oppdatert 28. sep. 2026 · NCT04706663

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

RekruttererFase 1/2
  • Research Site, Ann Arbor
Alder 18 til 130 · Menn · Oppdatert 25. sep. 2026 · NCT07181161

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

RekruttererFase 2
  • VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

RekruttererFase 3
  • University of Michigan ( Site 0005), Ann Arbor
Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT06925737

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

RekruttererFase 3
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Chelsea Hospital, Chelsea · 15 mi unna
  • og 2 flere
Alder 18 og eldre · Menn · Oppdatert 10. sep. 2026 · NCT05946213

Prostate Active Surveillance Study

RekruttererObservasjonsstudie
  • University of Michigan, Ann Arbor
Alder 21 og eldre · Menn · Oppdatert 2. sep. 2026 · NCT00756665

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

RekruttererObservasjonsstudie
  • Rogel Cancer Center, Ann Arbor
Alder 18 og eldre · Menn · Oppdatert 27. aug. 2026 · NCT07050433

EDRN Prostate MRI Biomarker Study

RekruttererObservasjonsstudie
  • University of Michigan, Ann Arbor
Alder 18 og eldre · Menn · Oppdatert 17. aug. 2026 · NCT03784924

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

RekruttererFase 2
  • University of Michigan Health, Ann Arbor
Alder 18 og eldre · Menn · Oppdatert 14. aug. 2026 · NCT04812366

SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy

RekruttererObservasjonsstudie
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
Alder 18 og eldre · Menn · Oppdatert 27. jul. 2026 · NCT07096999

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

RekruttererFase 3
  • Veteran's Administration Medical Center - Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi unna
Alder 18 og eldre · Menn · Oppdatert 14. jul. 2026 · NCT06592924

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

RekruttererFase 2
  • VA Ann Arbor Healthcare System, Ann Arbor
Alder 18 og eldre · Menn · Oppdatert 15. jun. 2026 · NCT05422911

Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer

RekruttererObservasjonsstudie
  • University of Michigan Rogel Cancer Center, Ann Arbor
Alder 35 til 70 · Menn · Oppdatert 12. jun. 2026 · NCT07645391

Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

RekruttererFase 1/2
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
Alder 18 og eldre · Menn · Oppdatert 5. mai 2026 · NCT06616155

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

RekruttererFase 2/3
  • VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Alder 18 og eldre · Menn · Oppdatert 8. apr. 2026 · NCT04787744

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

RekruttererFase 3
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 mi unna
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
  • og 4 flere
Alder 18 og eldre · Menn · Oppdatert 22. jan. 2026 · NCT06470243

A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

Rekrutterer
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
Alder 18 og eldre · Alle kjønn · Oppdatert 21. jan. 2026 · NCT07291414

Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])

RekruttererFase 2
  • University of Michigan Rogel Cancer Center, Ann Arbor
Alder 18 og eldre · Menn · Oppdatert 16. jan. 2026 · NCT05038332

Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

RekruttererFase 2Frivillige helsepersonell ønskes velkommen
  • VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Alder 18 og eldre · Menn · Oppdatert 31. des. 2025 · NCT06084338

Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe

RekruttererObservasjonsstudie
  • University of Michigan Rogel Cancer Center, Ann Arbor
Alder 40 til 80 · Menn · Oppdatert 24. nov. 2025 · NCT05965180

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservasjonsstudie
  • Massive Bio SYNERGY-AI site, Ann Arbor
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

RekruttererFase 3
  • Saint Joseph Mercy Hospital, Ann Arbor
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
  • Saint Joseph Mercy Chelsea, Chelsea · 15 mi unna
  • og 1 flere
Alder 18 og eldre · Menn · Oppdatert 11. sep. 2025 · NCT03678025

Prostatakreft-studier i andre byer

Andre studier i Ann Arbor

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.